BeOne Medicines (ONC) Shares Outstanding (2015 - 2026)
BeOne Medicines (ONC) posted quarterly Shares Outstanding (Entity) of $1.5 billion for Q1 2026, up 9.81% year-over-year from $1.4 billion in Q1 2025, and little changed quarter-over-quarter from $1.5 billion in Q4 2025.
BeOne Medicines (ONC) Shares Outstanding (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported Shares Outstanding (Entity) for 12 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 9.81% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 9.81% YoY), while the FY2025 annual figure was $1.5 billion, up 11.07% from the prior year.
- Shares Outstanding (Entity) was little changed at $1.5 billion in Q1 2026 per ONC's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $1.5 billion in Q2 2025 and bottomed at $1.3 billion in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 12.04% — and 2024, when it fell 0.23%.
- BeOne Medicines' Shares Outstanding (Entity) stood at $1.4 billion in 2022, then grew by 0.25% to $1.4 billion in 2023, then grew by 2.05% to $1.4 billion in 2024, then advanced by 11.07% to $1.5 billion in 2025, then changed by 0.0% to $1.5 billion in 2026.
- Business Quant data shows ONC's Shares Outstanding (Entity) at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 720.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Bn |
| Mar 31, 2026 | 1.44 Bn |
| Dec 31, 2025 | 1.42 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.41 Bn |
| Mar 31, 2025 | 1.39 Bn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.38 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.36 Bn |
| Dec 31, 2023 | 1.36 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.36 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 1.35 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.33 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.21 Bn |